NCT02097680View on ClinicalTrials.gov

Influence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese Men

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Obesity
Interventions
DRUG

Letrozole

One Letrozole 2.5 mg capsule every two days during four months

DRUG

Placebo

One placebo capsule every two days during four months

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT02097680 - Influence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese Men | Biotech Hunter | Biotech Hunter